Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruiting
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Central Nervous System Disease · Multiple Sclerosis
United States
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States
- Pain Phenotypes in Individuals With Multiple SclerosisNot Yet Recruiting
Sponsor: Kutahya Health Sciences University
Multiple Sclerosis · Chronic Pain
Turkey (Türkiye)
- Effects of Face-to-Face Versus Telerehabilitation-Based Circuit Training in People With Multiple SclerosisNot Yet Recruiting
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis
Turkey (Türkiye)
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States
- Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyRecruiting
Sponsor: University of Texas at Austin
Multiple Sclerosis · Pathologic Processes · Demyelinating Autoimmune Diseases, CNS · Autoimmune Diseases of the Nervous System
United States
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.Active Not Recruiting
Sponsor: Sanofi
Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +42 more
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis
Australia, France, Germany, Hungary, Italy +6 more
- Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple SclerosisActive Not Recruiting
Sponsor: Rigshospitalet, Denmark
Relapsing Remitting Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Primary Progressive Multiple Sclerosis
Denmark
- PLasmatic Extracellular Vesicles AS Biomarkers of nEural Tissue DamageNot Yet Recruiting
Sponsor: Roberto Furlan
Multiple Sclerosis · Stroke
Sponsor: Louis Stokes VA Medical Center
Spinal Cord Injury/Disorder · Stroke · Multiple Sclerosis · Traumatic Brain Injury
United States
Sponsor: Hacettepe University
Multiple Sclerosis
Turkey (Türkiye)
Sponsor: Luzerner Kantonsspital
Stroke · Traumatic Brain Injury · Multiple Sclerosis
Switzerland
Sponsor: The University of Texas at Dallas
Multiple Sclerosis, Relapsing-Remitting
United States
Sponsor: Kite, A Gilead Company
Chronic Inflammatory Demyelinating Polyneuropathy · Myasthenia Gravis · Multiple Sclerosis
United States, Australia, Canada
Sponsor: Oculis
Optic Neuritis
United States
Sponsor: Sanofi
Multiple Sclerosis
United States, Belgium, China, Italy, Japan
- Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)Not Yet Recruiting
Sponsor: Eva M.M. Strijbis
Multiple Sclerosis
Sponsor: Genentech, Inc.
Multiple Sclerosis
Puerto Rico
Sponsor: Istanbul Bilgi University
Multiple Sclerosis, MS
Turkey (Türkiye)
- Novel Imaging Markers in SPMSCompleted
Sponsor: University of Utah
Secondary Progressive Multiple Sclerosis · Multiple Sclerosis, Secondary Progressive · Multiple Sclerosis
United States
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Argentina, China, Dominican Republic, Finland +18 more
- Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisNot Yet Recruiting
Sponsor: Assiut University
Multiple Sclerosis
Egypt
- Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple SclerosisNot Yet Recruiting
Sponsor: Cairo University
Multiple Sclerosis
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Brazil, Mexico, United Kingdom